ITEM 2:
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Unless indicated otherwise, or the context otherwise requires, references in this report to the “Company,” “Morgan Group,” “Morgan,” “we,” “us,” and “our” or similar
terms are to Morgan Group Holding Co. and its subsidiary.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Our disclosure and analysis in this Form 10-Q contains some forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements because they do not relate
strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” “should,” “may,” and other words and terms of similar meaning. They also appear in any discussion
of future operating or financial performance. In particular, these include statements relating to future actions, future performance of our products, expenses, the outcome of any legal proceedings, and financial results. Although we believe that
we are basing our expectations and beliefs on reasonable assumptions within the bounds of what we currently know about our business and operations, there can be no assurance that our actual results will not differ materially from what we expect
or believe. We are providing these statements as permitted by the Private Litigation Reform Act of 1995. We do not undertake to update publicly any forward-looking statements if we subsequently learn that we are unlikely to achieve our
expectations or if we receive any additional information relating to the subject matters of our forward-looking statements.
OVERVIEW
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included
in Part I, Item 1 of this Form 10-Q. This discussion contains forward-looking statements and involves numerous risks and uncertainties. Our actual results could differ materially from those anticipated by such
forward-looking statements as discussed under “Cautionary Statement Regarding Forward-Looking Statements” appearing elsewhere in this Form 10-Q.
Morgan Group (OTC Pink®: MGHL), through G.research, acts as an underwriter and provides institutional research services. Institutional research services revenues consist of brokerage commissions derived from
securities transactions executed on an agency basis or direct payments from institutional clients as well as underwriting profits, selling concessions and management fees associated with underwriting activities. Commission revenues vary
directly with the perceived value of the research provided, as well as account activity and new account generation.
RESULTS OF OPERATIONS
The following table (in thousands, except per share data) and discussion of our results of operations are based upon data derived from the Condensed Consolidated Statements of Income contained in our condensed consolidated financial statements
and should be read in conjunction with those statements included in Part I, Item 1 of this Form 10-Q:
|
|
Three Months Ended March 31,
|
|
|
|
2023
|
|
|
2022
|
|
Revenues
|
|
|
|
|
|
|
Commissions
|
|
$
|
467
|
|
|
$
|
504
|
|
Principal transactions
|
|
|
(2
|
)
|
|
|
(0
|
)
|
Dividends and interest
|
|
|
31
|
|
|
|
5
|
|
Other revenues
|
|
|
1
|
|
|
|
0
|
|
Total revenues
|
|
|
497
|
|
|
|
509
|
|
Expenses
|
|
|
|
|
|
|
|
|
Compensation and related costs
|
|
|
291
|
|
|
|
328
|
|
Clearing charges
|
|
|
217
|
|
|
|
230
|
|
General and administrative
|
|
|
221
|
|
|
|
225
|
|
Occupancy and equipment
|
|
|
45
|
|
|
|
73
|
|
Total expenses
|
|
|
774
|
|
|
|
856
|
|
Loss before income tax benefit
|
|
|
(276
|
)
|
|
|
(347
|
)
|
Income tax benefit
|
|
|
-
|
|
|
|
-
|
|
Net loss
|
|
$
|
(276
|
)
|
|
$
|
(347
|
)
|
|
|
|
|
|
|
|
|
|
Net loss per share
|
|
|
|
|
|
|
|
|
Basic and diluted
|
|
$
|
(0.46
|
)
|
|
$
|
(0.58
|
)
|
Three Months Ended March 31, 2023 as Compared to the Three Months Ended March 31, 2022
Revenues
Institutional research services revenues by revenue component, excluding principal transactions and dividends and interest, were as follows (dollars in thousands):
|
|
Three Months Ended March 31,
|
|
|
Increase (Decrease)
|
|
|
|
2023
|
|
|
2022
|
|
|
|
|
|
$
|
%
|
|
Commissions
|
|
$
|
442
|
|
|
$
|
460
|
|
|
$
|
(18
|
)
|
|
|
(3.9%
|
)
|
Hard dollar payments
|
|
|
25
|
|
|
|
44
|
|
|
|
(19
|
)
|
|
|
(42.5%
|
)
|
Total
|
|
$
|
467
|
|
|
$
|
504
|
|
|
$
|
(36
|
)
|
|
|
(7.2%
|
)
|
Institutional research service revenues were $.5 million for three months ended March 31, 2023 and March 31, 2022, respectively. For the three months ended March 31, 2023 and 2022, respectively, G.research earned $0.3
million and $0.3 million, or approximately 70% and 55%, of its commission revenue from transactions executed on behalf of funds advised by Gabelli Funds, LLC (“Gabelli Funds”) and clients advised by GAMCO Asset Management Inc. (“GAMCO Asset”).
Principal Transactions
During the three months ended March 31, 2023 and 2022, net losses from principal transactions were negligible.
Interest and dividend income was $31 thousand for the three months ended March 31, 2023 an increase of $26 thousand from $5 thousand for the three months ended March 31, 2022 due to a sharp increase in short-term
interest rates during the same period.
Expenses
Total expenses were $.8 million for the three months ended March 31, 2023, a decrease of $0.1 million, or 9.6%, from $.9 million in the 2022 period. The decrease results primarily from lower compensation costs and a
reduction of expenses across all categories.
Compensation costs, which includes salaries, bonuses, and benefits, were $0.3 million for the three months ended March 31, 2023 and March 31, 2022, respectively.
Income Tax Benefit
We recorded an income tax provision of $0.0 million and $0 for the three months ended March 31, 2023 and 2022, respectively. The effective tax rate was (0.9)% and 0% for the periods ended March 31, 2023 and 2022,
respectively.
Net Loss
Net loss for the three months ended March 31, 2023 was $0.3 million versus $0.3 million for the three months ended March 31, 2022.
LIQUIDITY AND CAPITAL RESOURCES
Our principal assets are highly liquid in nature and consist of cash and cash equivalents, comprised primarily of a 100% U.S. Treasury money market fund, The Gabelli U.S. Treasury Money Market Fund, advised by
Gabelli Funds, LLC, which is an affiliate of the Company. Summary cash flow data for the first three months of 2023 and 2022 was as follows (in thousands):
|
|
Three Months Ended March 31,
|
|
|
|
2023
|
|
|
2022
|
|
Cash flows provided by (used in):
|
|
|
|
|
|
|
Operating activities
|
|
$
|
65
|
|
|
$
|
36
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
65
|
|
|
|
36
|
|
Cash and cash equivalents at beginning of period
|
|
|
2,635
|
|
|
|
3,239
|
|
Cash and cash equivalents at end of period
|
|
$
|
2,700
|
|
|
$
|
3,275
|
|
Net cash provided by operating activities was $0.07 million for the three months ended March 31, 2023, resulting from a net loss of $0.3 million and net increase in operating liabilities of $0.1 million offset by and a
decrease in operating assets of $0.3 million. Net cash provided by operating activities was less than $0.1 million for the three months ended March 31, 2022, resulting from a net loss of $0.3 million less a net decrease in operating liabilities
of $0.1 million offset by a net decrease in operating assets of $0.5 million.
Critical Accounting Policies
The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting
periods presented. Actual results could differ significantly from those estimates. See Note B in Part II, Item 8, Financial Statements and Supplementary Data, and the Company’s Critical Accounting
Policies in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in Morgan Group’s 2022 annual report on Form 10-K filed with the SEC on March 31, 2023
for details on Critical Accounting Policies.
ITEM 4.
|
CONTROLS AND PROCEDURES
|
The Company maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be timely disclosed, is recorded, processed, summarized, and
reported to management within the time periods specified in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. The Company’s principal executive officer and principal financial officer, after evaluating the effectiveness of the Company’s
disclosure controls and procedures (as defined in the Exchange Act) as of the end of the period covered by this report, have concluded that the Company’s disclosure controls and procedures are effective to provide reasonable assurance that
information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial
officer, as appropriate, to allow timely decisions regarding required disclosure and are effective to provide reasonable assurance that such information is recorded, processed, summarized and reported within the time periods specified in the
SEC’s rules and forms.
There have been no changes in our internal control over financial reporting, as defined by Rule 13a-15(f) that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.